J&J/DePuy Spine launches Healos Fx
This article was originally published in The Gray Sheet
Executive Summary
Injectable bone graft replacement designed specifically for minimally invasive spine surgery debuts April 27. The 510(k)-cleared Healos Fx is a ready-to-use fibrous material that can be molded for open applications or "injected via cannulas of differing lengths to reach difficult implantation sites in minimally invasive or small void surgical environments," the firm states. When saturated with a patient's bone marrow, Healos Fx serves as a continuous scaffold for bone formation and the osteoprogenitor cells needed to initiate new bone growth, according to the company. Healos in strip form has been available in the U.S. for over seven years, the firm notes
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.